FBRX Recorded Big Gain

Wed 22 Jul 20 at 05:33 PM
FBRX Recorded Big Gain

FBRX (FBRX:NASDAQ) shot up at $20.96, representing a gain of 32%. On Tue 21 Jul 20, FBRX:NASDAQ hit a New 2-Week Intraday High of $16. From Tue 07 Jul 20, the stock recorded 50.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.


Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial in mid-2020.